Terms: = Lymphoma AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Clinical Outcome
2 results:
1. Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell lymphoma.
Lone W; Bouska A; Sharma S; Amador C; Saumyaranjan M; Herek TA; Heavican TB; Yu J; Lim ST; Ong CK; Slack GW; Savage KJ; Rosenwald A; Ott G; Cook JR; Feldman AL; Rimsza LM; McKeithan TW; Greiner TC; Weisenburger DD; Melle F; Motta G; Pileri S; Vose JM; Chan WC; Iqbal J
Clin Cancer Res; 2021 Nov; 27(21):6039-6053. PubMed ID: 34426436
[TBL] [Abstract] [Full Text] [Related]
2. Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.
Carballo-Zarate AA; Medeiros LJ; Fang L; Shah JJ; Weber DM; Thomas SK; Manasanch EE; Hao S; Shen Q; Orlowski RZ; Lin P; Lu X
Mod Pathol; 2017 Jun; 30(6):843-853. PubMed ID: 28281554
[TBL] [Abstract] [Full Text] [Related]
